title: Questions regarding frontline therapy of acute myeloid leukemia.
authors.forename: Hagop
authors.initials: H
authors.lastname: Kantarjian
authors.forename: Susan
authors.initials: S
authors.lastname: O'Brien
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000592:standards / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage*; D003630:Daunorubicin / Q000008:administration & dosage*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality; D008875:Middle Aged; D018365:Neoplasm, Residual / Q000188:drug therapy; D011379:Prognosis; D012074:Remission Induction; D019233:Retreatment
chemical_list: D003561:Cytarabine; D003630:Daunorubicin